Previous research has supported that LOXL1-AS1 can promote the development of different cancers, including pancreatic cancer [15], gastric carcinoma [16], non-small cell lung cancer [17] and HCC [17]. This evidence concerns the gene LOXL1 and familial pancreatic carcinoma.